| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,888 |
21,790 |
$1.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,571 |
9,182 |
$452K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,589 |
2,430 |
$190K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,758 |
2,551 |
$126K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,339 |
1,227 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
479 |
451 |
$50K |
| 99454 |
|
1,093 |
1,063 |
$35K |
| 99457 |
|
1,032 |
1,007 |
$27K |
| 99215 |
Prolong outpt/office vis |
299 |
265 |
$21K |
| 99490 |
Ccm add 20min |
4,210 |
4,066 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
864 |
756 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
756 |
720 |
$11K |
| 95923 |
|
132 |
125 |
$10K |
| 20610 |
|
482 |
164 |
$9K |
| 95943 |
|
107 |
101 |
$9K |
| 87632 |
|
34 |
34 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
37 |
37 |
$7K |
| 77002 |
|
244 |
67 |
$6K |
| 86318 |
|
384 |
368 |
$6K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
155 |
40 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,714 |
1,027 |
$5K |
| 99441 |
|
138 |
128 |
$4K |
| 87799 |
|
39 |
39 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
35 |
35 |
$3K |
| 77085 |
|
109 |
108 |
$3K |
| 92546 |
|
71 |
40 |
$3K |
| 87634 |
|
37 |
36 |
$3K |
| 94060 |
|
67 |
62 |
$2K |
| 87498 |
|
38 |
38 |
$1K |
| 87641 |
|
39 |
39 |
$1K |
| 99453 |
|
129 |
126 |
$1K |
| 87486 |
|
38 |
38 |
$1K |
| 87581 |
|
38 |
38 |
$1K |
| 87541 |
|
38 |
38 |
$1K |
| 87640 |
|
37 |
37 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
37 |
37 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
68 |
68 |
$1K |
| 93015 |
|
36 |
33 |
$1K |
| 94400 |
|
36 |
33 |
$927.30 |
| 94729 |
|
36 |
33 |
$902.62 |
| 94681 |
|
36 |
33 |
$892.56 |
| 93922 |
|
25 |
23 |
$846.90 |
| 95921 |
|
21 |
19 |
$698.86 |
| 94727 |
|
37 |
34 |
$694.38 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,039 |
896 |
$528.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
180 |
126 |
$457.74 |
| 90656 |
|
27 |
27 |
$406.97 |
| 90688 |
|
28 |
28 |
$399.24 |
| 99458 |
|
14 |
14 |
$310.98 |
| 92545 |
|
28 |
25 |
$282.47 |
| 93000 |
|
30 |
27 |
$280.26 |
| 93790 |
|
15 |
12 |
$269.99 |
| 92542 |
|
16 |
13 |
$216.29 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
474 |
403 |
$193.53 |
| 92541 |
|
15 |
12 |
$169.39 |
| 90686 |
|
18 |
12 |
$166.15 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
824 |
748 |
$153.51 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$151.10 |
| 0011A |
|
19 |
15 |
$135.52 |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
63 |
48 |
$134.38 |
| 92547 |
|
41 |
38 |
$125.39 |
| 99335 |
|
16 |
14 |
$116.88 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
343 |
194 |
$75.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
901 |
668 |
$47.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
115 |
103 |
$36.42 |
| 81002 |
|
14 |
12 |
$32.11 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
119 |
102 |
$22.78 |
| 99406 |
|
30 |
26 |
$11.44 |
| G2061 |
Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes |
17 |
14 |
$9.72 |
| 99422 |
|
14 |
13 |
$7.63 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
196 |
42 |
$3.92 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$1.46 |
| 3725F |
|
44 |
38 |
$0.00 |
| 99051 |
|
16 |
15 |
$0.00 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
108 |
90 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
64 |
54 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
18 |
$0.00 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
604 |
553 |
$0.00 |
| 91301 |
|
18 |
13 |
$0.00 |